Journal of General Internal Medicine

, Volume 9, Issue 4, pp 232–236 | Cite as

Electrolyte and acid-base disorders associated with AIDS

An etiologic review
  • Mark A. Perazella
  • Eric Brown
Clinical Review

Summary

In summary, patients with HIV infection may develop a bewildering variety of electrolyte and acid-base disturbances. Hyponatremia from many causes is common and associated with an increased mortality. Potassium disorders are frequent, with hyperkalemia, even to life-threatening levels, more common than hypokalemia. Disturbances in calcium and uric acid homeostasis are less frequent. Acid-base disorders also complicate the clinical course of AIDS and, as with the electrolyte perturbations, may result from HIV infection itself, the illnesses associated with AIDS, or medications.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Farizo KM, Buehler JW, Chamberland ME, et al. Spectrum of disease in persons with human immunodeficiency virus infection in the United States. JAMA. 1992;267:1798–805.PubMedCrossRefGoogle Scholar
  2. 2.
    Grinspoon SK, Bilezikian JP. HIV disease and the endocrine system. N Engl J Med. 1992;327:1360–5.PubMedCrossRefGoogle Scholar
  3. 3.
    Bourgoignie JJ. Renal complications of human immunodeficiency virus type 1. Kidney Int. 1990;37:1571–84.PubMedGoogle Scholar
  4. 4.
    Glassock RJ, Cohen AH, Danovitch G, et al. Human immunodeficiency virus (HIV) infection and the kidney. Ann Intern Med. 1990;1 12:35–49.Google Scholar
  5. 5.
    Seney FD, Burns DK, Silva FG. Acquired immunodeficiency syndrome and the kidney. Am J Kidney Dis. 1990;16:1–13.PubMedGoogle Scholar
  6. 6.
    Glasgow BJ, Steinsapir KD, Anders K, et al. Adrenal pathology in the acquired immune deficiency syndrome. Am J Clin Pathol. 1985;84:594–7.PubMedGoogle Scholar
  7. 7.
    Agarwal A, Soni A, Ciechanowsky M, et al. Hyponatremia in patients with the acquired immunodeficiency syndrome. Nephron. 1989;53:317–21.PubMedCrossRefGoogle Scholar
  8. 8.
    Vitting KE, Gardenswartz MH, Zabetakis PM, et al. Frequency of hyponatremia and nonosmolar vasopressin release in the acquired immunodeficiency syndrome. JAMA. 1990;263:973–8.PubMedCrossRefGoogle Scholar
  9. 9.
    Cusano AJ, Thies HI., Siegal FP, et al. Hyponatremia in patients with acquired immune deficiency syndrome. J Acquir Immune Defic Syndr. 1990;3:949–53.PubMedGoogle Scholar
  10. 10.
    Tang WW, Kaptein EM, Feinstein EI, et al. Hyponatremia in hospitalized patients with the acquired immunodeficiency syndrome (AIDS) and the AIDS-related complex. Am J Med. 1993;94:169–74.PubMedCrossRefGoogle Scholar
  11. 11.
    Peter SA. Electrolyte disorders and renal dysfunction in acquired immunodeficiency syndrome patients. J Natl Med Assoc. 1991;83:889–91.PubMedGoogle Scholar
  12. 12.
    Mc’Ligeyo SO, Otieno LS, Mwongera FK. Urinalysis and electrolyte profiles in patients with acquired immunodeficiency syndrome. Trop Geogr Med. 1991;43:33–8.PubMedGoogle Scholar
  13. 13.
    Vaziri ND, Barbari A, Licorish K, et al. Spectrum of renal abnormalities in acquired immune-deficiency syndrome. J Natl Med Assoc. 1985;77:369–75.PubMedGoogle Scholar
  14. 14.
    Kalin ME, Poretsky L, Seras DS, et al. Hyporeninemic hypoaldo-steronism associated with the acquired immune deficiency syndrome. Am J Med. 1987;82:1035–8.PubMedCrossRefGoogle Scholar
  15. 15.
    Poretsky L, Maran A, Zumoff B. Endocrinologic and metabolic manifestations of the acquired immunodeficiency syndrome. Mt Sinai J Med. 1990;57:236–41.PubMedGoogle Scholar
  16. 16.
    Strauss KW. Endocrine complications of the acquired immunodeficiency syndrome. Arch Intern Med. 1991;151:1441–4.PubMedCrossRefGoogle Scholar
  17. 17.
    Levine AM, Gill PS, Cohen J, et al. Suramin antiviral therapy in the acquired immunodeficiency syndrome. Ann Intern Med. 1986;105:32–6.PubMedGoogle Scholar
  18. 18.
    Ashby H, DiMattina M, Linehan WM, et al. The inhibition of human steroidogenic enzyme activities by suramin. J Clin Endocrinol Metab. 1989;68:505–8.PubMedCrossRefGoogle Scholar
  19. 19.
    Berns JS, Cohen RM, Stumacher RJ, et al. Renal aspects of therapy for human immunodeficiency virus and associated opportunistic infections. J Am Soc Nephrol. 1991;1:1061–80.PubMedGoogle Scholar
  20. 20.
    Medina I, Mills J, Leoung G, et al. Oral therapy forPneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone. N Engl J Med. 1990;323:776–82.PubMedCrossRefGoogle Scholar
  21. 21.
    Velazquez H, Perazella MA, Wright FS, et al. Renal mechanism of trimethoprim induced hyperkalemia. Ann Intern Med. 1993;119:296–301.PubMedGoogle Scholar
  22. 22.
    Briceland LL, Bailie GR. Pentamidine-associated nephrotoxicity and hyperkalemia in patients with AIDS. DICP Ann Pharmacother. 1991;25:1171–4.Google Scholar
  23. 23.
    Herchline TE, Plouffe JF, Para MF. Diabetes mellitus presenting with ketoacidosis following pentamidine therapy in patients with AIDS. J Inf. 1991;22:41–4.CrossRefGoogle Scholar
  24. 24.
    Lachaal M, Venuto RC. Nephrotoxicity and hyperkalemia in patients with acquired immunodeficiency syndrome treated with pentamidine. Am J Med. 1989;87:260–3.PubMedCrossRefGoogle Scholar
  25. 25.
    Sebastian A, Schambelan M. Renal hyperkalemia. Semin Nephrol. 1987;7:223–38.PubMedGoogle Scholar
  26. 26.
    Calabrese L, Proffitt M, Yen-Lieberman B, et al. Congestive cardiomyopathy and illness related to AIDS associated with isolation of retrovirus from myocardium. Ann Intern Med. 1987;107:691–2.PubMedGoogle Scholar
  27. 27.
    Berman A, Espinoza LR, Diaz JD. Rheumatic manifestations of HIV infection. Am J Med. 1988;85:59–64.PubMedCrossRefGoogle Scholar
  28. 28.
    Fulop M. Hyperkalemia in diabetic ketoacidosis. Am J Med Sci. 1990;299:164–9.PubMedCrossRefGoogle Scholar
  29. 29.
    Smith PD, Quinn TC, Strober W, et al. Gastrointestinal infections in AIDS. Ann Intern Med. 1992;116:63–77.PubMedGoogle Scholar
  30. 30.
    Zaloga GP, Chernow B, Eli C. Hypercalcemia and disseminated cytomegalovirus infection in the acquired immunodeficiency syndrome. Ann Intern Med. 1985;102:331–3.PubMedGoogle Scholar
  31. 31.
    Zikos D, Block RD, Cheng JC, et al. AIDS-related hypercalcemia crisis. A potential mechanism [abstract]. Kidney Int. 1989;35:388.Google Scholar
  32. 32.
    Jacobs MB. The acquired immunodeficiency syndrome and hypercalcemia. West J Med. 1986;144:469–71.PubMedGoogle Scholar
  33. 33.
    Maesaka JK, Cusano AJ, Thies HL, et al. Hypouricemia in acquired immunodeficiency syndrome. Am J Kidney Dis. 1990;15:252–7.PubMedGoogle Scholar
  34. 34.
    Mizock BA. Lactic acidosis. Dis Mon. 1989;34:233–300.Google Scholar
  35. 35.
    Gopinath R, Hutcheon M, Cheema-Dhadli S, et al. Chronic lactic acidosis in a patient with acquired immunodeficiency syndrome and mitochondrial myopathy: biochemical studies. J Am Soc Nephrol. 1992;3:1212–9.PubMedGoogle Scholar
  36. 36.
    Chattha G, Arieff Al, Cummings G, et al. Lactic acidosis complicating the acquired immunodeficiency syndrome. Ann Intern Med. 1993;118:37–9.PubMedGoogle Scholar
  37. 37.
    Schneiderman DJ, Arenson DM, Cello JP, et al. Hepatic disease in patients with AIDS. Hepatology. 1987;7:925–37.PubMedCrossRefGoogle Scholar

Copyright information

© the Society of General Internal Medicine 1994

Authors and Affiliations

  • Mark A. Perazella
    • 1
  • Eric Brown
    • 2
  1. 1.Yale Primary Care Residency Program, Department of MedicineSt. Mary’s HospitalWaterbury
  2. 2.the Department of Medicine, Section of NephrologyYale University School of MedicineNew Haven

Personalised recommendations